From Financial Modeling Prep: 2025-03-06 20:00:04

In summary, Merck KGaA reported earnings per share of $2.14, falling short of estimates, with revenue at $5.61 billion. The company projects up to 8% currency-adjusted operating earnings growth for the year. Merck remains a key player in the pharmaceutical and chemical industries, with a diverse portfolio and strategic initiatives driving growth. Key financial metrics highlight the company’s strong market presence and financial health.



Read more at Financial Modeling Prep:: Merck KGaA’s Financial Overview and Market Positio…